Oncoinvent ASA (KLDVK) — Financial Flexibility Index

Latest as of December 2025: 0.03x

Oncoinvent ASA (KLDVK) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of Nkr5.76 Million (operating CF Nkr3.64 Million minus capex Nkr2.12 Million) represents 0% of total liabilities (Nkr230.30 Million). Also explore KLDVK shareholders equity momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.03x
Free Cash Flow / Total Liabilities

Free Cash Flow

Nkr5.76 Million
Operating CF − Capex

Total Liabilities

Nkr230.30 Million
NOK

Capital Expenditures

Nkr2.12 Million
NOK

Oncoinvent ASA Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. Check KLDVK strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Oncoinvent ASA (2021–2025)

Year-by-year free cash flow to debt coverage for Oncoinvent ASA. For the full company profile including market capitalisation, see how much is Oncoinvent ASA worth.

Year Flexibility Index Free Cash Flow (NOK) Operating CF Total Liabilities YoY Change
2025 -0.04x Nkr-8.47 Million Nkr-23.24 Million Nkr230.30 Million ▼ -187.0%
2024 0.04x Nkr9.07 Million Nkr-14.84 Million Nkr214.71 Million ▲ +129.2%
2023 -0.14x Nkr-20.79 Million Nkr-40.23 Million Nkr143.77 Million ▼ -238.3%
2022 0.10x Nkr12.50 Million Nkr373.06K Nkr119.51 Million ▼ -80.0%
2021 0.52x Nkr31.01 Million Nkr130.66K Nkr59.25 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities